– (1) MORE SHELF SPACE at the selling area of drug outlets
– (2) very few CONSUMERS of a drug product are that loyal to a brand they will NOT TRY ANOTHER COMPANY
– (3) creating new brands DEVELOP HEALTHY COMPETITION within the manufacturer’s
organization comprising several Product divisions or subsidiary companies
– (4) a multibranding strategy positions brands on DIFFERENT BENEFITS AND APPEALS and each
brand can ATTRACT a separate following when positioned in several target market segments
• Ex. Unilever, P&G
– (1) it should CLOSELY SUGGEST something about the PRODUCT'S BENEFITS AND QUALITIES that
the intended markets could associate with easily.
EX. (Diatabs, Stresstabs, Licealiz, fungisol, drivemax, neurobion)
– (2) it should be EASY TO PRONOUNCE, RECOGNIZE, AND REMEMBER.
– (3) it should be DISTINCTIVE to readily arrest ATTENTION.
– (1) that will SATISFACTORILY CATER to the NEEDS of drug outlets in terms of CONVENIENCE and EASE OF HANDLING
– (2) that end users will favorably RESPOND TO AT SHORT NOTICE
– (3) physicians and dentists to PRESCRIBE with HIGHER CONFIDENCE
– (4) pharmacists and allied professionals will readily ENDORSE OUT OF A HIGH-QUALITY PERCEPTION of the drug product
– (5) that will generate GREATER PRODUCT AWARENESS, immediate trials and repeat purchases associated with the distinct and unique power of good innovative packaging.
1 Width (different product category,
ex. Analgesic, anti-infective)
2 Length (different brand name or diff generic name that they can possibly do under the same category ex. – ibuprofen, paracetamol, aspirin, medicol)
3 Depth
4 Consistency
WeL DC